ketanserin has been researched along with Lung Diseases, Obstructive in 5 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Lung Diseases, Obstructive: Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To indirectly test the hypothesis whether serotonin (5-HT) might have a role in the increase in pulmonary vascular resistance, we evaluated the haemodynamic and gas exchange response of intravenous ketanserin (K), a 5-HT receptor inhibitor, in eight severe but stable patients with chronic obstructive pulmonary disease with secondary pulmonary hypertension (mean pulmonary artery pressure (Ppa) 30." | 7.69 | Haemodynamic effects of ketanserin either alone or with oxygen in COPD patients with secondary pulmonary hypertension. ( Domenighetti, G; Feihl, F; Leuenberger, P, 1997) |
| "To indirectly test the hypothesis whether serotonin (5-HT) might have a role in the increase in pulmonary vascular resistance, we evaluated the haemodynamic and gas exchange response of intravenous ketanserin (K), a 5-HT receptor inhibitor, in eight severe but stable patients with chronic obstructive pulmonary disease with secondary pulmonary hypertension (mean pulmonary artery pressure (Ppa) 30." | 3.69 | Haemodynamic effects of ketanserin either alone or with oxygen in COPD patients with secondary pulmonary hypertension. ( Domenighetti, G; Feihl, F; Leuenberger, P, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cazzola, M | 3 |
| Matera, MG | 1 |
| D'Amato, G | 3 |
| Rossi, F | 1 |
| Domenighetti, G | 1 |
| Leuenberger, P | 1 |
| Feihl, F | 1 |
| Guidetti, E | 1 |
| Sepe, J | 2 |
| Assogna, G | 2 |
| Lucchetti, G | 1 |
| Santangelo, G | 1 |
| Hamet, A | 1 |
| Král, B | 1 |
| Cernohorský, D | 1 |
| Lobefalo, G | 1 |
| Guillaro, B | 1 |
| Pietroletti, R | 1 |
| Lauria, D | 1 |
1 review available for ketanserin and Lung Diseases, Obstructive
| Article | Year |
|---|---|
Effects of serotonin on airways: recent developments.
Topics: Allergy and Immunology; Animals; Bronchitis; Chronic Disease; Humans; Inflammation Mediators; Ketans | 1995 |
2 trials available for ketanserin and Lung Diseases, Obstructive
| Article | Year |
|---|---|
Acute respiratory and cardiovascular effects of inhaled ketanserin in chronic obstructive pulmonary disease. A comparative study with intravenously administered ketanserin.
Topics: Administration, Inhalation; Adult; Aged; Blood Pressure; Double-Blind Method; Female; Forced Expirat | 1990 |
Ketanserin, a new blocking agent of serotonin S2-receptors. Respiratory functional effects in chronic obstruction of the airways.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Female; Forced Expirator | 1987 |
2 other studies available for ketanserin and Lung Diseases, Obstructive
| Article | Year |
|---|---|
Haemodynamic effects of ketanserin either alone or with oxygen in COPD patients with secondary pulmonary hypertension.
Topics: Female; Hemodynamics; Humans; Hypertension, Pulmonary; Ketanserin; Lung Diseases, Obstructive; Male; | 1997 |
Comparative effects of oxygen, nifedipine and ketanserin in hypoxic pulmonary hypertension.
Topics: Adult; Carbon Dioxide; Cardiac Output; Female; Heart Rate; Humans; Hypertension, Pulmonary; Hypoxia; | 1985 |